![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valneva Se | LSE:0OB3 | London | Ordinary Share | FR0004056851 | VALNEVA ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 3.455 | 3.37 | 3.54 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
115,392 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 175.73M | -101.43M | -0.7302 | -4.56 | 479.94M |
Date | Time | Source | Headline |
---|---|---|---|
06/2/2025 | 17:00 | UKREG | Shareholding declaration Valneva SE - January 2025 |
06/2/2025 | 17:00 | UKREG | Déclaration d'actions et de droits de vote de la société Valneva SE -.. |
05/2/2025 | 06:00 | UKREG | Valneva reçoit une autorisation de mise sur le marché au Royaume-Uni pour.. |
05/2/2025 | 06:00 | UKREG | Valneva Receives Marketing Authorization in the UK for the World’s First.. |
30/1/2025 | 16:45 | UKREG | Valneva Announces New IXIARO® Supply Contract with the U.S. Government.. |
30/1/2025 | 16:45 | UKREG | Valneva annonce un nouveau contrat d’une valeur minimale de $32.8 millions.. |
22/1/2025 | 16:45 | UKREG | Valneva Reports Positive Phase 2 Results in Children for its Chikungunya.. |
22/1/2025 | 16:45 | UKREG | Valneva annonce des résultats de Phase 2 positifs chez les enfants pour son.. |
20/1/2025 | 16:45 | UKREG | Valneva Reports High Sustained Immune Response in Adolescents One Year.. |
20/1/2025 | 16:45 | UKREG | Valneva annonce une réponse immunitaire robuste et durable chez les.. |
1 Year Valneva Chart |
Intraday Valneva Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions